---
$id: https://graph.org.ai/products/commodity/51111907
$type: Product
source: UNSPSC
code: "51111907"
title: "Sodium phenylbutyrate"
class: "51111900"
classTitle: "Natural antineoplastic products"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium phenylbutyrate

**UNSPSC Code**: 51111907
**Class**: [Natural antineoplastic products](Natural antineoplastic products.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phenylbutyrate and antineoplastic agent with the molecular formula C10H11O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NT6K61736T, chemically known as benzenebutanoic acid, sodium salt but generally known as sodium phenylbutyrate, which bears US NIH Compound Identifier 15585. European Medicines Agency schedules Sodium phenylbutyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12586MIG. World Health Organization schedules sodium phenylbutyrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SODIUM PHENYLBUTYRATE remains the US FDA Preferred Term for this commodity. Sodium phenylbutyrate bears US NLM identifiers UMLS ID C0718066 and NCI Concept Code C1440. SMILES: C1=CC=C(C=C1)CCCC(=O)[O-].[NA+].

